Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. It is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.
Ticker SymbolAMIX
Company nameAutonomix Medical Inc
IPO dateJan 29, 2024
CEOMr. Bradley (Brad) Hauser
Number of employees8
Security typeOrdinary Share
Fiscal year-endJan 29
Address- -
City- -
Stock exchangeNASDAQ Capital Market Consolidated
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolAMIX
IPO dateJan 29, 2024
CEOMr. Bradley (Brad) Hauser
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data